Recent advances in diagnostic technologies, systemic therapy and local therapy have increased the precision of personalized gastrointestinal (GI) and genitourinary (GU) oncology. This rapidly evolving landscape challenges clinical care teams to better coordinate multi-disciplinary care and stay on the cutting edge for optimal patient outcomes. This year’s symposium will explore the latest procedures, technology and medical treatments for patients with GI and GU cancers. Recent national guidelines will be reviewed and emphasis will be given to multi-disciplinary care, recently FDA-approved drug therapies and upcoming clinical trials. Ample time will be given for case discussions by a multidisciplinary panel and attendees are invited to submit their clinical cases to mboone2@emory.edu.

Contact

Melissa Boone, 404-727-1626; mboone2@emory.edu

Website

cmetracker.net/EMORY/Login?FormName=RegLoginLive&Eventid=13427